Blue Belt Technologies Receives CE Mark for Navio PFS System

Blue Belt Technologies, Inc., a medical device company focused on developing the next generation of "smart" surgical instruments providing precise robotic control for use initially in orthopedic procedures and then for other surgical specialties including neurosurgery, spinal and otolaryngology ("ENT"), announced today that it has received CE Mark for the Navio™ PFS System.

The Company's initial market application in Europe is for Unicondylar Knee Replacement ("UKR") which is commonly known as partial knee replacement. A partial knee replacement is surgery to replace either the inside (medial) or outside (lateral) compartment of the knee with an implant. Partial knee replacements are bone-sparing and have been shown to provide better surgical outcomes for patients with cartilage damage contained to a single compartment when compared to total joint replacement. The majority of partial knee replacement surgeries are currently performed using instruments which can be inconsistent and lead to high revision and retreatment rates.

Medtronic Announces 510(k) Clearance for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery

Medtronic, Inc. (NYSE:MDT) announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for the Aquamantys® SBS 5.0 Sheathed Bipolar Sealer, a new addition to the spine portfolio of the company’s Advanced Energy business.

“We are excited to offer surgeons this new addition to our ever-growing spine portfolio of advanced energy products”

Zimmer объявил о приобретении Synvasive Technology, Inc.

Zimmer объявил о приобретении Synvasive Technology, Inc.

Zimmer Holdings, Inc. (NYSE and SIX: ZMH) announced today that it has acquired Reno, Nevada-based Synvasive Technology, Inc. The acquisition will enhance Zimmer's product portfolio through the addition of Synvasive's STABLECUT® surgical saw blades, as well as the eLIBRA® Dynamic Knee Balancing System™ for soft tissue balancing.


"Zimmer is committed to developing the industry's most innovative range of technologies to support personalized therapies, from improved surgical power equipment to patient specific instrumentation and other intelligent tools that support optimal surgical outcomes," said Jeff McCaulley, President, Zimmer Reconstructive. "The acquisition of Synvasive Technology further strengthens our surgical resection and advanced instrumentation offerings."


In the surgical resection market, Synvasive has long been recognized as a leader in surgical cutting tools with its STABLECUT® blades. Synvasive's eLIBRA® Dynamic Knee Balancing System™ is the premiere soft-tissue balancing solution in the industry. This offering provides patient specific soft-tissue balancing during knee replacement surgery, establishing the optimal position of the femoral implant to enable a less-invasive surgical approach as well as excellent stability, range of motion and patella tracking.

Biomet получило регистрацию FDA на два новых продукта: 
E1® Humeral Bearing для системы Comprehensive® Reverse Shoulder 
и систему Comprehensive® Segmental Revision

Biomet, Inc., мировой лидер в сфере ортопедии и биотехнологии, сегодня обявил о регистрации двух своих систем в United States Food and Drug Administration (FDA), это:  E1® humeral bearing для использования совместно с  Comprehensive® Reverse Shoulder System, а также Comprehensive® Segmental Revision System. 

 "Этот продукт специально разработан для решения проблем дефицита костной ткани при ревизионных и онкологических вмешательствах."


 The E1® humeral bearing with exclusive Antioxidant-Infused Technology is the first Vitamin E advanced bearing option for reverse shoulder applications. Biomet first applied the clinically successful1 E1® technology to its hip and knee products. The integration of E1® technology into the Comprehensive® Reverse Shoulder portfolio will provide surgeons and patients with an advanced bearing surface with oxidative stability, high strength and low wear.2,3 

 "Biomet is the first company to bring advanced bearing surfaces to the shoulder," said John Sperling, MD, orthopaedic surgeon, Rochester, Minnesota. "The outstanding wear characteristics and proven track record of E1® bearings will provide a tremendous benefit to patients undergoing reverse shoulder arthroplasty." 

 The FDA also cleared Biomet's Comprehensive® Segmental Revision System (SRS), a humeral replacement system designed to address significant bone loss, both proximally and distally. The Comprehensive® SRS offers oncologic options, soft tissue attachments, and multiple sizing options, and is compatible with the Comprehensive® Shoulder system and the Discovery® Elbow system. 

 "The Comprehensive® SRS is a breakthrough in shoulder and elbow arthroplasty design," said Dr. Sperling. "This system is specifically designed to address humeral bone deficiency in revision and oncologic settings." 

 "This system is particularly helpful for surgeons specializing in revision shoulder or elbow surgery where modularity and intra-operative flexibility is critical," said Quin Throckmorton, MD, orthopaedic surgeon, Memphis, Tennessee. 

Ellipse Technologies заявило о первой имплантации системы дистанционного контроля удлинения конечности PRECICE в США

Monday, January 9, 2012

Ellipse Technologies

заявило о первой имплантации системы дистанционного контроля удлинения конечности PRECICE в США

Ellipse Technologies, Inc. (далее “Ellipse”) сегодня заявили о том, что первая установка системы дистанционного контроля удлинения конечности  PRECICE в Соединенных Штатах была успешно проведена в декабре доктором Dror Paley, Директором Paley Advanced Limb Lengthening Institute, в West Palm Beach, штат Florida. Удлинение конечности используется в лечении ряда заболеваний, включая восстановление длины при врожденных пороках, тяжелых переломах и других медицинских проблемах включая укорочении при хирургическом лечении онкологических больных.